Why Are Bone Biologics Shares Surging On Monday?

Why Are Bone Biologics Shares Surging On Monday?

Newly listed Bone Biologics Corporation BBLG shares are surging after the Company announced to present at the H.C. Wainwright BioConnect Virtual Conference.

  • Bone Biologics is focused on regenerative medicine for bone. 
  • The Company is working on the Nell-1 protein, a bone graft substitute product on bone regeneration in spinal fusion, and has rights to trauma and osteoporosis applications.
  • Recombinant NELL-1 is purified and mixed with 510-K-cleared Demineralized Bone Matrix putty in the operating room.
  • As per the latest presentation, in preclinical studies, spine fusion effectiveness was demonstrated across 3 animal species.
  • Preclinical studies have shown increases in spine fusion by 37.5% compared to the control.
  •  The pivotal sheep study evaluated the effect of rhNELL-1 combined with DBX on lumbar interbody arthrodesis in an adult ovine model to support initiation of a pilot clinical study in Australia and IDE approval from the FDA.
  • According to the Company presentation on the Website, the FDA has accepted pilot study data in Australia to enable US pivotal study.
  • The Human Research Ethics Committee (HREC) approved the First in Man study in Australia with 30 subjects.
  • Price Action: BBLG shares are up 85.70% at $6.35 during the market session on the last check Monday.

Posted In: Briefswhy it's movingBiotechLong IdeasNewsHealth CareMoversTrading IdeasGeneral